Pancreatic Cancer Research

ResearcherAffiliated Hospital of Nantong UniversityNo recent work listed

Hao Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8874-0673; OpenAlex author ID A5100353599. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers

Papers 3

  1. Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. Co-author DOI 10.1007/s10637-020-00951-0↗
  2. USP51, an oncogene for pancreatic cancer (PC) cell growth via Wnt/β-catenin pathway Co-author DOI 10.21203/rs.3.rs-20243/v1↗
  3. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jcb.27119↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yihui Fan · 2 shared papers, 2018–2020 · strength 0.20
  2. Renfang Mao · 2 shared papers, 2018–2020 · strength 0.20
  3. Guo-Xiong Zhou · 2 shared papers, 2018–2020 · strength 0.20
  4. Erhao Zhang · 1 shared paper, 2020 · strength 0.11
  5. Yong-Qiang Hua · 1 shared paper, 2020 · strength 0.10
  6. Zhouyu Ning · 1 shared paper, 2020 · strength 0.10
  7. Luming Liu · 1 shared paper, 2020 · strength 0.10
  8. Zhiqiang Meng · 1 shared paper, 2020 · strength 0.10
  9. Yingcheng Charles Wu · 1 shared paper, 2018 · strength 0.08
  10. Yue Ming · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.